
    
      The patients were divided into two groups. One received probiotics for 45 days and the second
      received placebo. The patients had a clinical and epidemiological as well as nutritional
      assessment. They were followed-up as for their bowel movements, abdominal pain and nosocomial
      infections and for the incidence of helicobacter pylori and clostridiume difficille diarrhea.
    
  